TECH Estatísticas principais
Alta
72.12
Abrir
71.60
Volume
3.07M
Baixa
71.50
Fechamento anterior
71.77
Valor negociado
221.03M
52 sem. máx.
72.16
Vol. relativo
0.367
Amplitude (%)
0.86%
52 sem. mín.
43.20
Taxa de giro
1.96%
Cap. de Mercado
11.18B
P/L (TTM)
103.59
P/L (Anual)
153.447
P/VP
5.39
P/S
9.28
Lucro por ação (EPS)
0.696
Dividendo (TTM)
0.317
Rendimento de dividendos
0.45%
Ações em circulação
156.56M
Unidade monetária
USD
TECH Desempenho de Preço
7 dia
30 dia
90 dia
180 dia
No acumulado do ano
1 Ano
TECH Distribuição do fluxo de dinheiro
TECH Volume diário de venda a descoberto
TECH Histórico de short interest
TECH Visão geral da ação
As of 2026-07-18, the Bio-Techne Corp (TECH) stock price today is 72.12. Based on this price, the company has a market capitalization of $11.18B, with a P/E ratio of 103.59.
On 2026-07-18, TECH traded between 71.50 and 72.12. Today’s stock price is 0.87% above the daily low and 0.00% below the daily high, placing TECH perto da extremidade superior de its most recent trading range.
Trading volume currently stands at 3.07M, compared with an average daily volume of 8.38M. This suggests that trading activity is significativamente abaixo do nível habitual than usual.
Over the past year, Bio-Techne Corp shares have traded between 43.20 and 72.16. At today’s price, TECH is 66.94% above its 52-week low and 0.06% below its 52-week high.
TECH Notícias relacionadas
Sobre TECH
Nome empresa
Bio-Techne Corp
Setor
Health Technology
Indústria
Biotechnology
Trocas
Nasdaq
Número de funcionários
3,100
Tamanho do lote
100
Site oficial
Unidade monetária
USD
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
Related Stocks
© 2026 CoinGlass, all rights reserved
